Peng Ding Lu Wen Fan Tong Ruiguang Zhang Yu Huang Xiaorong Dong
10.20517/cdr.2021.104
Cancer Drug Resist
2022 Feb 8;5(1):147-164.
immune checkpoint inhibitors hyper-progressive disease immunotherapy tumor microenvironment
CC BY
https://pubmed.ncbi.nlm.nih.gov/35582541/
Review
PMC8992596
35582541
Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer
2022